logo
ENTITY
Raqualia Pharma

Raqualia Pharma (4579 JP)

3
Analysis
Health Care • Japan
RaQualia Pharma, Inc. is a pharmaceutical company. The Company develops compounds for patient studies and sells drugs to pharmaceutical manufacturers. RaQualia also provides research on remedies in gastrointestinal, liver diseases, and pain in general areas.
more
bullish•Raqualia Pharma
•15 Nov 2024 09:00•Issuer-paid

Raqualia Pharma (4579 JP): Q3 FY12/24 flash update

Operating revenue increased to JPY2.4bn (+58.4% YoY), with a net loss of JPY340mn, driven by rising R&D expenses. Royalty income from four...

Logo
Shared Research
120 Views
Share
bullish•Raqualia Pharma
•15 Aug 2024 11:00•Issuer-paid

Raqualia Pharma (4579 JP): 1H FY12/24 flash update

Operating revenue increased to JPY1.4bn (+39.1% YoY), with an operating loss of JPY154mn and a recurring loss of JPY278mn. Royalty income from...

Logo
Shared Research
180 Views
Share
bullish•Raqualia Pharma
•11 Oct 2018 17:48

Investment Thesis and Valuation

Key Drivers Stable income of ¥ 0.5b - ¥1b from Animal Healthcare segment Pharma segment – royalty income from Tegoprazan (South K approved June...

Logo
Share
No more insights

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x